Expand CRVS Menu
CRVS MENU

CRVS Latest Press Releases

-- April 21, 2026 --

Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting Globe Newswire 7:30 AM

-- March 12, 2026 --

Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 4:01 PM

-- March 5, 2026 --

Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026 Globe Newswire 4:01 PM

-- February 23, 2026 --

Corvus Pharmaceuticals to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference Globe Newswire 4:01 PM

-- January 23, 2026 --

Corvus Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $201M Globe Newswire 5:00 PM

-- January 21, 2026 --

Corvus Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock Globe Newswire 10:53 PM

-- January 20, 2026 --

Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Globe Newswire 4:01 PM
Corvus Pharmaceuticals Announces Positive Data from Cohort 4 Confirming Results for Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis Globe Newswire 7:00 AM

-- January 16, 2026 --

Corvus Pharmaceuticals to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis Globe Newswire 4:01 PM

-- January 5, 2026 --

Corvus Pharmaceuticals Confirms Plans to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis in January 2026 Following Annual Healthcare Conference Globe Newswire 8:30 AM

-- December 8, 2025 --

Corvus Pharmaceuticals Presents Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial Globe Newswire 10:30 AM
Market Data Delayed 15 Minutes